Skip to content
Find Clinical Trials

Study assessing the glucose-lowering efficacy and safety of luseogliflozin on top of metformin in Caucasian patients with type 2 diabetes mellitus

Servier Protocol Code: CL3-LUSEO-001 Sponsor: JSC Servier (Russia)

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00

Interventions / Treatments
  • Diabetes - Type II
  • Luseogliflozin
Other study id numbers
  • CL3-LUSEO-001